GlassScriptPhysician profile
Scott Marshall Pollack
NPI 1033679212
$5,536.64
in general payments reported to CMS, 2019-2025
19 companies · $1,711 in 2025
The $1,711 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.35 · 2021: $1,308 · 2022: $410 · 2023: $493 · 2024: $1,595 · 2025: $1,711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,799.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,225.87 | 2021 | |
| Alcon Vision LLC | $1,200.88 | 2022-2025 | Rocklatan, Argos, Hydrus Microstent |
| Abbvie INC. | $890.99 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $542.66 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Sight Sciences, INC. | $485.66 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Regeneron Healthcare Solutions, INC. | $276.37 | 2023-2024 | Eylea Hd |
| Tarsus Pharmaceuticals, INC. | $208.96 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $151.36 | 2023-2025 | Cequa |
| Apellis Pharmaceuticals, INC. | $124.99 | 2024 | Syfovre |
| Oyster Point Pharma, INC. | $102.87 | 2024-2025 | Tyrvaya, Ryzumvi |
| Glaukos Corporation | $93.35 | 2025 | Idosetr |
| Mallinckrodt Hospital Products INC. | $43.67 | 2021 | |
| Horizon Therapeutics Plc | $38.43 | 2021 | |
| Harrow Eye, LLC | $33.18 | 2025 | Vevye |
| Rxsight INC | $28.34 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24.02 | 2023 | Endoflip |
| Thea Pharma INC. | $23.49 | 2025 | Iyuzeh |
| Vital Connect, INC | $22.20 | 2024 | Vitalpatch Rtm |
| Allergan, INC. | $19.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Pollack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.